Back to top

Morgan Stanley Keeps Their Hold Rating on Arcus Biosciences (RCUS)

Morgan Stanley analyst Terence Flynn maintained a Hold rating on Arcus Biosciences today and set a price target of $23.00. According to TipRanks, F...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Arcus Biosciences, Inc. (RCUS)